Literature DB >> 7750352

Fatal hemoptysis in Ehlers-Danlos syndrome. Old malady with a new curse.

B A Yost1, J P Vogelsang, J T Lie.   

Abstract

We describe the case of a 27-year-old man with Ehlers-Danlos syndrome, type IV. The patient had recurrent and eventually fatal pulmonary hemorrhage. Type IV Ehlers-Danlos syndrome is a rare disorder of type III collagen synthesis. It is characterized by an unusual facies, thin, translucent skin with venous vascular pattern, and hypermobility of the small joints. The cause of death is usually due to rupture of a viscus or a major arterial hemorrhage and, in women, rupture of the gravid uterus. Fatal lung hemorrhage in Ehlers-Danlos syndrome, to our knowledge, has not been previously described.

Entities:  

Mesh:

Year:  1995        PMID: 7750352     DOI: 10.1378/chest.107.5.1465

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  The role of postmortem study in the diagnosis of the cause of death in a young man: a rare case of Ehlers-Danlos syndrome type IV.

Authors:  Natalia Escribano; Ileana Medina; Luis Ortega; M José Jiménez; M Concepción Millana; Roberto Fernández; Paloma Aragoncillo; Juliana Fariña
Journal:  BMJ Case Rep       Date:  2010-03-26

2.  Total pleural covering technique for intractable pneumothorax in patient with Ehlers-Danlos syndrome.

Authors:  Yoshihisa Kadota; Eriko Fukui; Naoto Kitahara; Eiji Okura; Mitsunori Ohta
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-12-16

3.  The vascular Ehlers-Danlos syndrome.

Authors:  Dominique P Germain
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

Review 4.  Ehlers-Danlos syndrome type IV.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2007-07-19       Impact factor: 4.123

5.  Vascular Ehlers-Danlos syndrome with cryptorchidism, recurrent pneumothorax, and pulmonary capillary hemangiomatosis-like foci: A case report.

Authors:  Min A Park; So Youn Shin; Young Jin Kim; Myung Jae Park; Seung Hyeun Lee
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.